Loading institutional data...
Loading institutional data...
Held by 2,112 of 5,944 reporting institutions (100th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $147.40 today, the market must believe free cash flow compounds 20.0%/yr for a decade (off $2.0B normalized FCF).
The market's 20.0% is more optimistic than its 9-yr track record.
2-stage DCF · 0.56B shares · net debt $13.1B
mean 147.4% · volatility σ 361% · implied rate exceeded in 3/7 yrs
Central path = implied 20.0%/yr growth; shaded band = ±1σ (361%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $29.49T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $371.6B | 42.5× | 29.7× | 5.5× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.8B | 38.5× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $259.8B | 39.0× | 18.5× | 2.9× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $199.4B | 79.4× | 40.2× | 2.2× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $185.4B | 37.1× | — | 4.1× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $177.4B | 47.9× | 31.6× | 5.5× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $167.6B | 23.6× | 16.1× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $158.8B | 39.2× | — | 5.8× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.2B | 28.1× | 16.1× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.2B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $118.7B | 34.1× | 26.8× | 6.0× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.3B | 24.9× | — | 4.9× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $96.2B | 23.0× | 16.9× | 1.8× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.4B | 32.6× | 23.3× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $92.4B | 70.8× | 43.8× | 9.0× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| PWR | $92.2B | 90.7× | 45.8× | 3.2× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| JCI | $91.9B | 28.0× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $90.7B | 60.9× | 39.9× | 11.0× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $87.3B | 27.4× | 16.8× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.0B | 31.8× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $85.0B | 15.3× | 9.5× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $83.0B | 36.5× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $79.8B | 45.0× | 28.7× | 7.7× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
Peers = companies sharing EMR's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.02B 100.0% | $17.49B 100.0% | $15.16B 100.0% | $1.66B 100.0% | $1.66B 100.0% | $12.93B 100.0% | $16.79B 100.0% | $18.37B 100.0% | $17.41B 100.0% | $15.26B 100.0% |
| Cost of Revenue | $8.50B 47.2% | $8.61B 49.2% | $7.74B 51.0% | — | $7.50B 451.7% | $7.20B 55.7% | $9.78B 58.2% | $10.56B 57.5% | $9.98B 57.3% | $8.83B 57.9% |
| Gross Profit | $9.52B 52.8% | $8.88B 50.8% | $7.43B 49.0% | — | $6.31B 379.9% | $7.56B 58.5% | $7.01B 41.8% | $7.82B 42.5% | $7.43B 42.7% | $6.40B 42.0% |
| Research & Development | $771.0M 4.3% | $781.0M 4.5% | $523.0M 3.4% | — | $385.0M 23.2% | $347.0M 2.7% | $439.0M 2.6% | $454.0M 2.5% | $436.0M 2.5% | $340.0M 2.2% |
| Selling, General & Admin | $5.10B 28.3% | $5.14B 29.4% | $4.19B 27.6% | — | $3.61B 217.7% | $3.49B 27.0% | $3.99B 23.7% | $4.46B 24.3% | $4.27B 24.5% | $3.61B 23.6% |
| Interest Expense | — | — | — | — | — | $147.0M 1.1% | — | — | — | — |
| Interest & Investment Income | $150.0M 0.8% | $148.0M 0.8% | $227.0M 1.5% | — | $34.0M 2.0% | $10.0M 0.1% | $19.0M 0.1% | $27.0M 0.1% | $43.0M 0.2% | $36.0M 0.2% |
| Other Income (Expense), net | $81.0M 0.4% | $72.0M 0.4% | $145.0M 1.0% | — | $100.0M 6.0% | $71.0M 0.5% | $12.0M 0.1% | $8.0M 0.0% | -$61.0M -0.4% | -$110.0M -0.7% |
| Pretax Income | $2.93B 16.3% | $2.02B 11.5% | $2.90B 19.1% | — | $2.43B 146.5% | $1.76B 13.6% | $2.33B 13.9% | $2.86B 15.6% | $2.67B 15.3% | $2.33B 15.3% |
| Income Tax Expense | $696.0M 3.9% | $415.0M 2.4% | $642.0M 4.2% | — | $549.0M 33.1% | $346.0M 2.7% | $345.0M 2.1% | $531.0M 2.9% | $443.0M 2.5% | $660.0M 4.3% |
| Net Income | $2.29B 12.7% | $1.97B 11.3% | $13.22B 87.2% | — | $3.23B 194.6% | $2.30B 17.8% | $1.97B 11.7% | $2.31B 12.6% | $2.20B 12.7% | $1.52B 9.9% |
| Per Share | ||||||||||
| EPS (Basic) | $4.06 | $3.44 | $23.00 | — | $5.44 | $3.85 | $3.26 | $3.74 | $3.48 | $2.35 |
| EPS (Diluted) | $4.04 | $3.43 | $22.88 | — | $5.41 | $3.82 | $3.24 | $3.71 | $3.46 | $2.35 |
| Weighted Avg Shares (Basic) | 564.0M | 571.3M | 574.2M | — | 592.9M | 598.1M | 602.9M | 616.2M | 632.0M | 642.1M |
| Weighted Avg Shares (Diluted) | 566.7M | 574.0M | 577.3M | — | 596.3M | 601.8M | 606.6M | 620.6M | 635.3M | 643.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 45% of free cash flow, leaving room to grow it and fund buybacks. Last year: $1.2B dividends + $1.2B buybacks = $2.4B returned on $2.7B FCF.
3 consecutive years of dividend increases · 1%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Insufficient data. Current ROIC on all capital: 7%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
$0 of principal comes due within a year. Scheduled principal only (excludes interest & revolver draws). As of 2025-09-30 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.” Effective rate ~2.2% on $6.7B of debt. Interest last disclosed in FY2021 (no longer broken out).
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
Where each multiple sits in its own 15-yr range · 85th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 15-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 57.5 | 58.2 | 55.7 | 451.7 | — | 51.0 | 49.2 | 47.2 |
| Gross Profit | 42.5 | 41.8 | 58.5 | 379.9 | — | 49.0 | 50.8 | 52.8 |
| R&D | 2.5 | 2.6 | 2.7 | 23.2 | — | 3.4 | 4.5 | 4.3 |
| SG&A | 24.3 | 23.7 | 27.0 | 217.7 | — | 27.6 | 29.4 | 28.3 |
| Income Tax | 2.9 | 2.1 | 2.7 | 33.1 | — | 4.2 | 2.4 | 3.9 |
| Net Income | 12.6 | 11.7 | 17.8 | 194.6 | — | 87.2 | 11.3 | 12.7 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on EMR: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.